CLOPIDOGREL CYP2C19 GENOTYPE

CLOPIDOGREL CYP2C19 GENOTYPING IS A GENETIC TEST THAT HELPS DETERMINE IF AN INDIVIDUAL IS LIKELY TO RESPOND EFFECTIVELY TO CLOPIDOGREL, A MEDICATION USED TO PREVENT BLOOD CLOTS. 1 THE CYP2C19 GENE ENCODES AN ENZYME RESPONSIBLE FOR ACTIVATING CLOPIDOGREL. 2 GENETIC VARIATIONS IN THIS GENE CAN AFFECT THE ENZYMES ACTIVITY, LEADING TO EITHER REDUCED OR ENHANCED METABOLISM OF THE DRUG. 3 BY IDENTIFYING THESE VARIATIONS, HEALTHCARE PROVIDERS CAN TAILOR CLOPIDOGREL THERAPY TO OPTIMIZE ITS EFFECTIVENESS AND MINIMIZE THE RISK OF ADVERSE EVENTS. 4